208 related articles for article (PubMed ID: 32715307)
21. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry.
Keller L; Marten S; Hecker J; Sahin K; Tittl L; Beyer-Westendorf J
Int J Cardiol; 2018 Apr; 257():276-282. PubMed ID: 29506708
[TBL] [Abstract][Full Text] [Related]
23. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
[TBL] [Abstract][Full Text] [Related]
24. The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry.
Cordeanu EM; Jambert L; Tousch J; Mirea C; Delatte A; Younes W; Woehl B; Harter C; Frantz AS; Hamade A; Schini-Kerth V; Ohlmann P; Andres E; Stephan D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888632
[TBL] [Abstract][Full Text] [Related]
25. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry.
Ageno W; Agnelli G; Imberti D; Moia M; Palareti G; Pistelli R; Verso M
Intern Emerg Med; 2013 Oct; 8(7):575-80. PubMed ID: 21660492
[TBL] [Abstract][Full Text] [Related]
27. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Raskob GE; van Es N; Segers A; Angchaisuksiri P; Oh D; Boda Z; Lyons RM; Meijer K; Gudz I; Weitz JI; Zhang G; Lanz H; Mercuri MF; Büller HR;
Lancet Haematol; 2016 Aug; 3(8):e379-87. PubMed ID: 27476789
[TBL] [Abstract][Full Text] [Related]
28. Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE1): A Study Protocol of a Non-Interventional Registry Study.
Yuanhua Y; Peifu T; Zhenguo Z; Xiaoying L
Adv Ther; 2019 Aug; 36(8):2180-2190. PubMed ID: 31140121
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
[TBL] [Abstract][Full Text] [Related]
30. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
[TBL] [Abstract][Full Text] [Related]
31. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
33. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).
Decousus H; Bourmaud A; Fournel P; Bertoletti L; Labruyère C; Presles E; Merah A; Laporte S; Stefani L; Piano FD; Jacquin JP; Meyer G; Chauvin F;
Blood; 2018 Aug; 132(7):707-716. PubMed ID: 29980524
[TBL] [Abstract][Full Text] [Related]
35. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.
Jara-Palomares L; Otero R; Jiménez D; Praena-Fernández JM; Rivas A; Font C; Wells PS; López-Reyes R; González-Martínez J; Monreal M
Clin Appl Thromb Hemost; 2018 Apr; 24(3):489-495. PubMed ID: 28681634
[TBL] [Abstract][Full Text] [Related]
36. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
[TBL] [Abstract][Full Text] [Related]
37. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
[TBL] [Abstract][Full Text] [Related]
38. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
39. Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.
Kenmotsu H; Notsu A; Mori K; Omori S; Tsushima T; Satake Y; Miki Y; Abe M; Ogiku M; Nakamura T; Takagi M; Ochiai H; Yasui H; Takahashi T
Cancer Med; 2021 Feb; 10(3):895-904. PubMed ID: 33421344
[TBL] [Abstract][Full Text] [Related]
40. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.
Barco S; Klok FA; Mahé I; Marchena PJ; Ballaz A; Rubio CM; Adarraga MD; Mastroiacovo D; Konstantinides SV; Monreal M;
Thromb Res; 2019 Jan; 173():166-171. PubMed ID: 30385047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
